Vanderbilt Digestive Disease Center — Nashville, Tennessee

Vanderbilt Digestive Disease Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Digestive Disease Center has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Primary Biliary Cirrhosis, Alcohol Associated Hepatitis, Non-Erosive Gastro-Esophageal Reflux Disease.

Sponsors: Ipsen, Intercept Pharmaceuticals, Phathom Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Digestive Disease Center?

Vanderbilt Digestive Disease Center has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Digestive Disease Center conducted?

Vanderbilt Digestive Disease Center has 7 clinical trials on record, with 3 currently active. Their work covers Primary Biliary Cirrhosis, Alcohol Associated Hepatitis, Non-Erosive Gastro-Esophageal Reflux Disease.

Is Vanderbilt Digestive Disease Center accredited by Crixeo Health?

Yes — Vanderbilt Digestive Disease Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vanderbilt Digestive Disease Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.